( As the topic of financing is vital to...)U.S. VC funding flat in 2005 while life science funding grows
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
U.S. VC funding flat in 2005 while life science funding grows
As the topic of financing is vital to a biotech company (it is priority #1, #2, and #3) and biotech (and I use "biotech" in the broadest sense) companies are continually faced with the challenge of raising money due to the long product development cycle, this week's article will focus on venture capital financing results for 2005.
Last week, we focused on V......
Full article >>>
'"/>
Source:wistechnology.com By Michael Rosen 02/06/06
Related biology technology :
1. Senate Democrats strip additional Act 255 funding from budget
2. Investor warns of angel-venture funding gap
3. Madison to receive funding as part of $60M solar energy program
4. GOP, Dems split over funding of state technology projects
5. Wisconsin applicants urged to pursue DOE funding for cellulosic biomass
6. Alzheimers drug developer lands $1.2M in venture funding
7. OpGen layoffs precede another funding round
8. Grow Milwaukee includes millions for tech funding
9. House passes bill to lift stem cell funding restrictions
10. BioSystem Development secures angel funding
11. Online retailer Jellyfish.com lands $5M in funding
Post Your Comments:
Breaking Biology Technology:Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4AEterna Zentaris Announces Appointment of New Board Member 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 2CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 3
[0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea[0] AEterna Zentaris Announces Appointment of New Board Member[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics[0] CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner
Other Biology Technology:Blue Cross BlueShield of South Carolina implements Esker solutions 2Standard Imaging acquires Canadian PIPSpro radiation treatment technologies 2
Breaking Biology News(10 mins):Physical education teaching staff play key role in making you like sport 2Pathological gambling may be successfully treated with medications for substance addiction 2No Immediate Changes Expected in Mammogram Coverage 61806 1No Immediate Changes Expected in Mammogram Coverage 61806 2No Immediate Changes Expected in Mammogram Coverage 61806 3In Memory of Patrick Swayze Songwriter Encourages People to Throw Away Cigarettes and Shell Give You Her New CD Free 21 61801 1Masimo to Present at the 21st Annual Piper Jaffray Health Care Conference 61796 1Masimo to Present at the 21st Annual Piper Jaffray Health Care Conference 61796 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |